Polyclonal intravenous immunoglobulin for the prophylaxis and treatment of infection in critically ill adults

Canadian Journal of Infectious Diseases

Volumn 13, Issue 2, 2002, Pages 100-106

  Laupland, Kevin B ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Critical care; Infection; Intensive care unit; Intravenous gamma globulin; Sepsis; Septic shock

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; IMMUNOGLOBULIN; LIPOPOLYSACCHARIDE;

ACUTE KIDNEY TUBULE NECROSIS; ADULT; ASEPTIC MENINGITIS; CENTRAL RETINA VEIN OCCLUSION; CLINICAL TRIAL; CONFERENCE PAPER; CRITICAL ILLNESS; DEEP VEIN THROMBOSIS; DRUG USE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; GRAM POSITIVE BACTERIUM; HEART INFARCTION; HUMAN; INCIDENCE; INFECTION; INFECTION PREVENTION; INFECTION RISK; INTENSIVE CARE UNIT; LENGTH OF STAY; META ANALYSIS; MORBIDITY; MORTALITY; MUCOCUTANEOUS LYMPH NODE SYNDROME; PNEUMONIA; POSTOPERATIVE INFECTION; RISK FACTOR; SEPSIS; SEPTIC SHOCK; STANDARD; STREPTOCOCCUS GROUP A; TOXIC SHOCK SYNDROME;

EID: 0036302882     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/2002/127953     Document Type: Conference Paper

References (39)

1. Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations
2. Has the mortality of septic shock changed with time?
3. Adjunctive therapy for septic shock: A review of experimental approaches
4. The staphylococcal enterotoxins and their relatives
5. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock
6. New therapies in sepsis
7. Critical care update in the new millenium
8. Intravenous immunoglobulin for treating sepsis and septic shock
9. Efficacy and safety of recombinant human activated protein C for severe sepsis
10. Present and future uses of IVIG: A Canadian multidisciplinary consensus-building initiative
11. Prophylactic intravenous administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of postsurgical infection
12. Polyvalent immunoglobulins for prophylaxis of bacterial infections in patients following multiple trauma. A randomized, placebo-controlled study
13. Differences in immunoglobulin preparations for intravenous use: A comparison of six products
14. Increased in vivo antibody activity against interferon α, interleukin-1α, and interleukin-6 after high dose Ig therapy
15. Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis
16. Randomized trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome
17. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome
18. Does Canada face a crisis? US considers ending plasma exports
19. Reduced incidence of postoperative infection after intravenous administration of an immunoglobulin A- and immunoglobulin M-enriched preparation in anergic patients undergoing cardiac surgery
20. Prevention of infection in multiple trauma patients by high-dose intravenous immunoglobulins
21. The injury severity score: A method for describing patients with multiple injuries and evaluating emergency care
22. Early administration of intravenous immunoglobulins in the prevention of surgical and post-traumatic sepsis: A double-blind randomized clinical trial
23. Effects of high-dose IgG on survival of surgical patients with sepsis scores of 20 or greater
24. APACHE II A severity of disease classification system
25. Sepsis score and complement factor B for monitoring severely septic surgical patients and for predicting their survival
26. High-dose intravenous IgG for treatment of severe surgical infections
27. Treatment of Gramnegative septic shock with an immunoglobulin preparation: A prospective, randomized clinical trial
28. Treatment of Gram-negative septic shock with an immunoglobulin preparation: A prospective, randomized clinical trial
29. Immunoglobulin therapy in patients with endotoxemia and post operative sepsis - A prospective randomized study
30. Immunoglobulin therapy of the postoperative sepsis
31. Intravenous immunoglobulins in association with antibiotics: A therapeutic trial in septic intensive care unit patients
32. Effect of adjuvant immunoglobulin therapy on infections in patients in a surgical intensive care unit. Results of a randomized controlled study
33. Supplemental immune globulins in sepsis
34. Supplemental immunoglobulin therapy in sepsis and septic shock - Comparison of mortality under treatment with polyvalent IV immunoglobulin versus placebo. Protocol of a multicenter, randomized, prospective, double-blind trial
35. Supplemental immune globulins in sepsis: A critical appraisal
36. Epidemiology, etiology, and management of Kawasaki Disease: State of the art
37. Roundtable conference on clinical trials for the treatment of sepsis
38. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome - A comparative observational study